Overview
Hiromichi Kai practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Atopic Dermatitis, ADULT Syndrome, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiromichi Kai
Is Hiromichi Kai a top-rated expert for Atopic Dermatitis?
MediFind is an objective health platform that identifies experts based on real-world data. Hiromichi Kai is classified as an Experienced expert for Atopic Dermatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiromichi Kai participate in research or clinical trials?
Yes. Hiromichi Kai has published 9 articles and abstracts on conditions like Atopic Dermatitis. You can view a list of Hiromichi Kai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ADULT SyndromeKai isExperienced. Learn about ADULT Syndrome.
- Atopic DermatitisKai isExperienced. Learn about Atopic Dermatitis.
- Cutaneous T-Cell Lymphoma (CTCL)
- Sezary SyndromeKai isExperienced. Learn about Sezary Syndrome.
- T-Cell LymphomaKai isExperienced. Learn about T-Cell Lymphoma.